Effects of oral enzymes in collagen II induced arthritis in mice

International Journal of Immunotherapy

Volumn 13, Issue 3-4, 1997, Pages 67-74

  Emancipator, S N ^a   Chintalacharuvu, S R ^a   Urankar Nagy, N ^a   Petersilge, C ^b   Stauder, G ^c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c Mucos Pharma GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; ENZYME; HYDROLASE; IBUPROFEN; PHLOGENZYM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKYLOSIS; ARTICLE; CARTILAGE; COMPUTER ANALYSIS; CONTROLLED STUDY; EDEMA; ENZYME THERAPY; FOOT PAD; IMMUNOTHERAPY; JOINT DEGENERATION; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; RADIOGRAPHY; RHEUMATOID ARTHRITIS;

EID: 0031396017     PISSN: 02559625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. van Zeben D., Breedveld FC Prognostic factors in rheumatoid arthritis. J. Rheumatol. Suppl., 44, 31, 1996.
2. Slotkoff A T., Katz P. Approach to the patient with rheumatoid arthritis. Adv. Intern. Med., 39, 197, 1994.
3. van Bruggen M.C.J., van den Broek M.F., van den Berg W.B. Streptococcal cell wall-induced arthritis and adjuvant arthritis in F344 to Lewis and in Lewis to F344 bone marrow chimeras. Cell. Immunol, 136, 278, 1991.
4. Steffen C., Zeitlhofer J., Menzel J , Smolen J. Die antigen-induzierte experimentelle Arthritis ais Prüfverfahren fur Entzündungshemmung durch oral applizierte Substanzen. Z. Rheumatol., 38, 264, 1979.
5. van den Berg W.B., van Beusekom H.J., van de Putte L.B.A , Zwarts W.A., van der Sluis M. Antigen handling in antigen-induced arthritis in mice. Am J. Pathol., 108, 9, 1982
6. Haqqi T.M., Anderson G.D., Banerjee S., David C.S Restricted heterogeneity in T-cell antigen receptor VB gene usage in the lymph nodes and arthritic joints of mice. Proc. Natl Acad. Sci. USA, 89, 1253, 1992
7. Banerjee S., Anderson G.D , Luthra H S , David C.S Influence of complement C5 and Vβ T-cell receptor mutations on susceptibility to collagen-induced arthritis in mice. J Immunol., 142, 2237, 1989.
8. Travaglio-Encinoza A , Chaouni I, Dersimonian H., et al. T-cell receptor distribution in rheumatoid synovial follicles J. Rheumatol., 22, 394, 1995
9. Miossec P., Chomarat P, Dechanet J Bypassing the antigen to control rheumatoid arthritis. Immunol. Today, 17, 170, 1996
10. Trentham D.E., Townes A S., Kang A H. Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med., 146, 857, 1977
11. Sieper J , Kingsley G Recent advances in the pathogenesis of reacitive arthritis Immunol. Today, 17, 160, 1996.
12. Chintalacharuvu S R., Emancipator S.N The glycosylation of IgA produced by munne B cells is altered by Th2 cytokines. J. Immunol , in press, 1997.
13. Joosten L.A.B., Helsen M.M.A., van de Loo F.A.J., van den Berg W.B. Anticytokine treatment of established type II collagen-induced arthrite in DBA/1 mice. Arthritis Rheum., 39, 797, 1996.
14. van den Berg W.B., Joosten L A B., Helsen M., van de Loo F.A.J. Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment. Clin Exp. Immunol., 95, 237, 1994.
15. Lehmann P.V. Immunomodulation by proteolytic enzymes Nephrol. Dial. Transplant., 11, 682, 1996.